antibody

Documents about antibody

• Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults#424233ClinicalTrials.gov
• Development of a novel histidine-rich glycoprotein measurement system as a biomarker for sepsis#428152OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• The structural and functional variance of IFN-γ in terms of cell and disease specificity and its effect on IFN-γ epitope binding.#637705SUNScholar
• Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results#643352HAL (France)
• Second-season Impact of Nirsevimab: Clinical Outcomes of RSV Disease in Patients Immunized During Their First Season.#672219Repisalud
• A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients#831875ClinicalTrials.gov
• A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors#831975ClinicalTrials.gov
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)#836986ClinicalTrials.gov
• Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease#838190ClinicalTrials.gov
• Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease#845495ClinicalTrials.gov
• Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma#856323ClinicalTrials.gov
• Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy#871576ClinicalTrials.gov
• A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)#875878ClinicalTrials.gov
• A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.#878809ClinicalTrials.gov
• Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo#888145ClinicalTrials.gov
• A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.#888793ClinicalTrials.gov
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)#870325ClinicalTrials.gov
• Monoclonal antibody levels and protection from COVID-19#201390UNSWorks Repository
• Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches#215401HAL (France)
• A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer#261515ClinicalTrials.gov
• Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma#300238ClinicalTrials.gov
• Antibody-secreting cells integrate efficient NMD with non‑canonical UPR signaling to maintain proteostasis and support massive immunoglobulin synthesis#347671HAL (France)
• A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)#356478ClinicalTrials.gov
• Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors#417531ClinicalTrials.gov
• Development of ultrafast protein digestion and standards free quantitation methods for mass spectrometric analysis#669028Digital Commons @ NJIT
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors#806920ClinicalTrials.gov
• Safety of TY027, a Treatment for COVID-19, in Humans#830242ClinicalTrials.gov
• A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer#853789ClinicalTrials.gov
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases#854779ClinicalTrials.gov
• A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas#860591ClinicalTrials.gov
• A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer#881553ClinicalTrials.gov
• Divergent Roles of mGlu2 and mGlu3 Receptors in Amyloid‐β Production and Cognitive Dysfunctions in Alzheimer's Disease#14214HAL (France)
• Immunomodulatory effects of acupuncture on inflammatory markers in patients with musculoskeletal pain: a systematic review of randomized controlled trials.#200327Figshare
• Antibody-Free and Highly Sensitive Detection of Site-Specific m⁶A Modification via Terminal-Mediated m⁶A PCR#229669Figshare
• Frequency of extractable nuclear antigen seropositivity among individuals seronegative for antinuclear antibodies on indirect immunofluorescence: a systematic review and meta-analysis#280569HAL (France)
• Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation#291395Gestión del Repositorio Documental de la Universidad de Salamanca
• Additional file 1 of Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysis#296753Figshare
• Caractérisation in silico des répertoires génomiques des immunoglobulines et des récepteurs de cellules T chez Gorilla gorilla gorilla#374502HAL (France)
• A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma#628547ClinicalTrials.gov
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes#826359ClinicalTrials.gov
• Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer#847770ClinicalTrials.gov
• MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer#856762ClinicalTrials.gov
• Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer#860182ClinicalTrials.gov
• Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease#877524ClinicalTrials.gov
• A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients#885435ClinicalTrials.gov
• Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety#4660Europe PMC
• Data from: Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle#215127Figshare
• Evaluation of post Vicinal Antibody Responses to Three Brands of Combined Vaccines Containing Canine Parvovirus Type 2 Following Single Administration in Nigerian Local Dogs. (Canine lupus familiaris)#228864University of Ibadan Institutional Repository
• Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey#249304African Journals Online
• Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia#811687ClinicalTrials.gov